CN101983712A - Novel medicament for treating coronary heart disease - Google Patents

Novel medicament for treating coronary heart disease Download PDF

Info

Publication number
CN101983712A
CN101983712A CN2010105085756A CN201010508575A CN101983712A CN 101983712 A CN101983712 A CN 101983712A CN 2010105085756 A CN2010105085756 A CN 2010105085756A CN 201010508575 A CN201010508575 A CN 201010508575A CN 101983712 A CN101983712 A CN 101983712A
Authority
CN
China
Prior art keywords
grams
heart disease
coronary heart
rhizoma
rhizoma corydalis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105085756A
Other languages
Chinese (zh)
Inventor
花倩妮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105085756A priority Critical patent/CN101983712A/en
Publication of CN101983712A publication Critical patent/CN101983712A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a novel medicament for treating coronary heart disease. The component proportion of the medicament is as follows: cucurbita pepo L.10g, cyperus Rotundus L.10g, flying squirrel feces 10g, red sage root 10g, peach seed 10g, polygala tenuifolia willd 10g, rhizoma corydalis 10g, curcuma tuber 10g, safflower 10g and ligusticum wallichii 10g. The accuracy of the ratio of the fixed dosages is plus or minus 10% of the above components. Indications of the medicament in the invention is coronary heart disease with the symptoms of deficient and weak of YANG QI, bardycardia and so on. The medicament has a safe, stable and obvious effect on treating coronary heart disease and is free of any toxic or side effect.

Description

The novel therapeutic medicine of coronary heart disease
Technical field
The present invention relates to a kind of oral traditional Chinese medicine medicine, specifically is a kind of novel therapeutic medicine of coronary heart disease.
Background technology
Coronary heart disease is a kind of modal heart disease, be meant the myocardial dysfunction that causes because of coronary stricture, blood supply insufficiency and (or) organic disease, so claim ischemic heart desease again, a kind of pain of squeezing property takes place in symptom performance thoracic cavity central authorities, and can delay to neck, chin, arm, back and stomach, other of outbreak may symptoms have dizzy, tachypnea, perspire, shiver, feel sick and faint.Severe patient may the death because of heart failure.Yet existing Chinese medicine and western medicine composition medicament therapeutic effect is unsatisfactory, often with side effect.
Summary of the invention
Exist some to treat unfavorable problem in order to solve in treatment coronary heart disease disease medicament, the invention provides the novel therapeutic medicine of coronary heart disease, the novel therapeutic medicine of this coronary heart disease cures mainly that insufficiency of heart-QI declines, deficiency of heart-YANG, bradycardia person's therapeutic effect are remarkable, the drug effect safety and stability, the cure rate height, without any side effects.
Concrete proportioning of the present invention is: golden melon 10 grams, Rhizoma Cyperi 10 grams, Oletum Trogopterori 10 grams, Radix Salviae Miltiorrhizae 10 grams, Semen Persicae 10 grams, Radix Polygalae 10 grams, Rhizoma Corydalis 10 grams, Radix Curcumae 10 grams, Flos Carthami 10 grams, Rhizoma Chuanxiong 10 grams, the degree of accuracy of the dose of this medicine be each medicine ± 10%.
The pharmacology of the Chinese medicine medicine of this treatment coronary heart disease is: golden melon: invigorating the spleen and replenishing QI, anti-inflammatory analgetic, detoxifcation parasite killing; Rhizoma Cyperi: the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving; The Oletum Trogopterori promoting blood circulation to remove blood stasis, the parch to black hemostasis; Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Semen Persicae: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma; Radix Polygalae: blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation, relieving cough and asthma; Rhizoma Corydalis: invigorate blood circulation promoting the circulation of QI, pain relieving; Radix Curcumae: regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice; Flos Carthami: promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; Rhizoma Chuanxiong:: the circulation of qi promoting expelling wind and activating blood circulation.
Preparing process of the present invention: Rhizoma Corydalis is gone into pot spray vinegar fry dried, Rhizoma Corydalis is 10: 1 with the amount ratio of vinegar, with the Rhizoma Corydalis after concocting and golden melon, Rhizoma Cyperi, Oletum Trogopterori, Radix Salviae Miltiorrhizae, Semen Persicae, Radix Polygalae, Rhizoma Corydalis, Radix Curcumae, Flos Carthami, Rhizoma Chuanxiong be mixed into sieve, clear water sieves and dashes, pulverize, machine makes ball and get final product.
Administrated method of the present invention is: every day three times, each 4-5 gram.
The invention has the beneficial effects as follows: the novel therapeutic medicine of this coronary heart disease cures mainly the coronary heart disease of symptoms such as insufficiency of heart-QI declines, deficiency of heart-YANG, bradycardia, and therapeutic effect is remarkable, the drug effect safety and stability, and the cure rate height, without any side effects.
Specific embodiment
Through over 3 years, the clinical practice to 100 examples are treated the patient of coronary heart disease has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment coronary heart disease, sex, age are not limit, stop using before the treatment other various medicines and therapeutic modality.
4. preparing process: Rhizoma Corydalis is gone into pot spray vinegar fry and do, Rhizoma Corydalis is 10: 1 with the amount ratio of vinegar, with the Rhizoma Corydalis after concocting and golden melon, Rhizoma Cyperi, Oletum Trogopterori, Radix Salviae Miltiorrhizae, Semen Persicae, Radix Polygalae, Rhizoma Corydalis, Radix Curcumae, Flos Carthami, Rhizoma Chuanxiong be mixed into sieve, clear water sieves and dashes, pulverize, machine makes ball and get final product.
5. administrated method: oral every day three times, each 4-5 gram.
6. efficacy evaluation
1. recovery from illness: transference cure.
2. remarkable: curing does not afterwards have recurrence more than 1 year.
3. effective: symptom significantly reduces.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat patients with coronary heart disease 100 examples altogether, male's 60 examples (60%) wherein, women's 40 examples (40%).
2. the course of disease: 1 month~5 months 25 examples, 6 months~1 year is 30 examples, 2 years~3 years 25 examples, 20 examples more than 3 years.
3. age group: 31~40 years old 15 example, 41~50 years old 20 example, 51~60 years old 30 example, 35 examples more than 60 years old.
4. prepare the dose scheme for first kind: golden melon 10 restrains, Rhizoma Cyperi 10 restrains, Oletum Trogopterori 10 restrains, Radix Salviae Miltiorrhizae 10 restrains, Semen Persicae 10 restrains, Radix Polygalae 10 restrains, Rhizoma Corydalis 10 restrains, Radix Curcumae 10 restrains, Flos Carthami 10 restrains, Rhizoma Chuanxiong 10 restrains.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 20 20 9 1
Moderate patient's 35 examples 10 22 2 1
Severe patient 15 examples 4 7 1 3
The scheme of second kind of preparation dose: golden melon 10 grams, Rhizoma Cyperi 10 grams, Oletum Trogopterori 10 grams, Radix Salviae Miltiorrhizae 10 grams, Semen Persicae 10 grams, Radix Polygalae 10 grams, Rhizoma Corydalis 10 grams, Radix Curcumae 10 grams, Flos Carthami 10 grams, Rhizoma Chuanxiong 10 grams.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 45 examples 28 10 6 1
Moderate patient's 40 examples 25 10 4 1
Severe patient 15 examples 3 8 3 1
The scheme of the third preparation dose: golden melon 10 grams, Rhizoma Cyperi 10 grams, Oletum Trogopterori 10 grams, Radix Salviae Miltiorrhizae 10 grams, Semen Persicae 10 grams, Radix Polygalae 10 grams, Rhizoma Corydalis 10 grams, Radix Curcumae 10 grams, Flos Carthami 10 grams, Rhizoma Chuanxiong 10 grams.
Patient's type Recovery from illness Significantly Effectively Invalid
Patients with mild 50 examples 30 15 4 1
Moderate patient's 40 examples 25 11 3 1
Severe patient 10 examples 5 3 2 1
By Drug therapy coronary heart disease sufferer of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and side effect is bigger, and human body is caused very major injury.In taking the process of medicine of the present invention, must not take Western medicine and use injection, or other treats this sick medicine.
The novel therapeutic medicine of this coronary heart disease cures mainly the coronary heart disease of symptoms such as insufficiency of heart-QI declines, deficiency of heart-YANG, bradycardia, and therapeutic effect is remarkable, the drug effect safety and stability, and the cure rate height, without any side effects.

Claims (2)

1. the novel therapeutic medicine of coronary heart disease, it is characterized in that: concrete proportioning of the present invention is golden melon 10 grams, Rhizoma Cyperi 10 grams, Oletum Trogopterori 10 grams, Radix Salviae Miltiorrhizae 10 grams, Semen Persicae 10 grams, Radix Polygalae 10 grams, Rhizoma Corydalis 10 grams, Radix Curcumae 10 grams, Flos Carthami 10 grams, Rhizoma Chuanxiong 10 grams, the degree of accuracy of this dose ratio be each medicine ± 10%.
2. the novel therapeutic medicine of coronary heart disease, it is characterized in that: preparation method of the present invention is fried dried for Rhizoma Corydalis being gone into pot spray vinegar, Rhizoma Corydalis is 10: 1 with the amount ratio of vinegar, with the Rhizoma Corydalis after concocting and golden melon, Rhizoma Cyperi, Oletum Trogopterori, Radix Salviae Miltiorrhizae, Semen Persicae, Radix Polygalae, Rhizoma Corydalis, Radix Curcumae, Flos Carthami, Rhizoma Chuanxiong be mixed into sieve, clear water sieves and dashes, pulverize, machine makes ball and get final product.
CN2010105085756A 2010-10-12 2010-10-12 Novel medicament for treating coronary heart disease Pending CN101983712A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105085756A CN101983712A (en) 2010-10-12 2010-10-12 Novel medicament for treating coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105085756A CN101983712A (en) 2010-10-12 2010-10-12 Novel medicament for treating coronary heart disease

Publications (1)

Publication Number Publication Date
CN101983712A true CN101983712A (en) 2011-03-09

Family

ID=43640877

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105085756A Pending CN101983712A (en) 2010-10-12 2010-10-12 Novel medicament for treating coronary heart disease

Country Status (1)

Country Link
CN (1) CN101983712A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104800772A (en) * 2015-05-08 2015-07-29 康莉 Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition
CN108653563A (en) * 2018-07-11 2018-10-16 利辛县运杰家庭农场 A kind of paste for nourishing heart and preparation method thereof for treating coronary heart disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104800772A (en) * 2015-05-08 2015-07-29 康莉 Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition
CN108653563A (en) * 2018-07-11 2018-10-16 利辛县运杰家庭农场 A kind of paste for nourishing heart and preparation method thereof for treating coronary heart disease

Similar Documents

Publication Publication Date Title
CN103071128B (en) Externally-applied plaster for curing dysmenorrhea
CN102813839B (en) Compound medicine for treating cluster headache syndrome
CN101961449B (en) Traditional Chinese medicine for treating tinea corporis
CN105362491A (en) External-use medicine for treating cervical vertebra hyperosteogeny
CN101912567B (en) Chinese medicinal prescription for treating chronic myocarditis
CN101983712A (en) Novel medicament for treating coronary heart disease
CN105477330A (en) Traditional Chinese medicine composition for treating arrhythmia
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN101129718B (en) Traditional Chinese medicine preparation for treating leuoderma
CN1245197C (en) Chinese medicine preparation for treating coronary heart disease and viral myocarditis
CN104225282A (en) Traditional Chinese medicine for treating postpartum headache
CN104042839A (en) Traditional Chinese medicine composition for treating tinea versicolor
CN110841007B (en) Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof
CN101979072A (en) Chinese medicament for treating chronic liver disease
CN104383211A (en) Traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy
CN104758346A (en) Medicine for treating migraine, as well as preparation method and preparation of medicine
CN104435883A (en) Traditional Chinese medicine preparation for treating calcaneodynia
CN103845555A (en) Traditional Chinese medicine for treating lumbocrural pain
CN104042728A (en) Traditional Chinese medicine for treating rectocele
CN102488877A (en) Traditional Chinese medicine composition for treating lung heat
CN101983670A (en) Medicament for treating gallstone
CN102078387A (en) Traditional Chinese medicine for treating fibroid and ovarian cyst
CN108452226A (en) A kind of Chinese medicine composition and preparation method thereof for treating infantile eczema and dermatitis
CN105770404A (en) Traditional Chinese medicine for treating heart disease
CN105381188A (en) Traditional Chinese medicine composition for treating chronic hepatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110309